Yingji Jin is Associate Director of the Cell Line Development group at Samsung Biologics. Yingji has over 15 years of experience in the pharmaceutical industry. She joined Samsung Biologics in 2018 and has led multiple stable CLD projects for various clients. Yingji also established multiple platforms such as the afucosylated cell line, lectin assay, and transient expression for CLD. She holds a doctorate degree in Virology from Chung-Ang University.